XTL Biopharmaceutica (Israel) Price on May 15, 2023

XTLB Stock  ILS 6.30  0.10  1.56%   
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. As of today, the current price of XTL Biopharmaceutica stands at 6.30, as last reported on the 22nd of January, with the highest price reaching 6.40 and the lowest price hitting 6.10 during the day. XTL Biopharmaceutica appears to be very steady, given 3 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.0795, which attests that the company had a 0.0795 % return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for XTL Biopharmaceuticals, which you can use to evaluate the volatility of the company. Please utilize XTL Biopharmaceutica's Mean Deviation of 3.94, downside deviation of 3.89, and Risk Adjusted Performance of 0.0754 to validate if our risk estimates are consistent with your expectations.
  
XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0795

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsXTLB
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.98
  actual daily
44
56% of assets are more volatile

Expected Return

 0.4
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.08
  actual daily
6
94% of assets perform better
Based on monthly moving average XTL Biopharmaceutica is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding it to a well-diversified portfolio.

XTL Biopharmaceutica Valuation on May 15, 2023

It is possible to determine the worth of XTL Biopharmaceutica on a given historical date. On May 15, 2023 XTL was worth 4.2 at the beginning of the trading date compared to the closed value of 4.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find XTL Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XTL Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XTL Biopharmaceutica's related companies.
 Open High Low Close Volume
  4.20    4.30    4.20    4.30    112,000  
05/15/2023
  4.20    4.30    4.20    4.30    52,200  
  4.30    4.60    4.30    4.50    533,104  
Backtest XTL Biopharmaceutica  |  XTL Biopharmaceutica History  |  XTL Biopharmaceutica Valuation   PreviousNext  
Open Value
4.2
4.3
Closing Value
19.13
Upside

XTL Biopharmaceutica Trading Date Momentum on May 15, 2023

On May 16 2023 XTL Biopharmaceuticals was traded for  4.50  at the closing time. The highest price during the trading period was 4.60  and the lowest recorded bid was listed for  4.30 . The volume for the day was 533.1 K. This history from May 16, 2023 contributed to the next trading day price jump. The trading price change to the next closing price was 4.65% . The trading price change to the current price is 2.33% .

XTL Biopharmaceuticals Fundamentals Correlations and Trends

By evaluating XTL Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XTL Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XTL financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About XTL Biopharmaceutica Stock history

XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel.

XTL Biopharmaceutica Stock Technical Analysis

XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of XTL Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of XTL Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

XTL Biopharmaceutica Period Price Range

Low
January 22, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

XTL Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

XTL Biopharmaceutica January 22, 2025 Market Strength

Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals entry and exit signals to maximize returns

XTL Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for XTL Stock analysis

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals